Page last updated: 2024-08-23

clavulanic acid and sulbactam

clavulanic acid has been researched along with sulbactam in 173 studies

Research

Studies (173)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (30.06)	18.7374
1990's	68 (39.31)	18.2507
2000's	29 (16.76)	29.6817
2010's	19 (10.98)	24.3611
2020's	5 (2.89)	2.80

Authors

Authors	Studies
Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T	1
Joyeau, R; Labia, R; Molines, H; Wakselman, M	1
Gottstein, WJ; Haynes, UJ; McGregor, DN	1
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN	1
Anzic, B; Copar, A; Mesar, T; Prevec, T; Selic, L; Solmajer, T; Vilar, M	1
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Girlich, D; Leclercq, R; Naas, T; Nordmann, P	1
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J	1
Hawley, JS; Jorgensen, JH; Murray, CK	1
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B	1
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D	1
Lombardo, F; Obach, RS; Waters, NJ	1
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR	1
Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J	1
Hesse, L; Paukner, S; Prezelj, A; Solmajer, T; Urleb, U	1
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A	1
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M	1
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS	1
Black, MT; Bruneau, JM; Claudon, M; Coleman, K; Frère, JM; Miossec, C; Péchereau, MC; Stachyra, T	1
Bethel, CR; Bonomo, RA; Caselli, E; Drawz, SM; Dwulit-Smith, JR; Papp-Wallace, KM; Prati, F; Rodkey, EA; Romagnoli, C; Smith, KM; Taracila, MA; van den Akker, F; Winkler, ML; Xu, Y	1
Bethel, CR; Bonomo, RA; Buynak, JD; Carey, PR; Chai, W; Che, T; Ding, Z; Nottingham, M; Pusztai-Carey, M; Rodkey, EA; Shanmugam, S; van den Akker, F	1
Bonomo, RA; Currie-McCumber, C; Shlaes, DM	1
Hedberg, M; Lindqvist, L; Nord, CE; Tunér, K	2
Griggs, DJ; Piddock, LJ; Traynor, EA	1
Lewis, N; Liu, H	1
Bawdon, RE; Dax, JB; Gilstrap, LC; Maberry, MC; Sobhi, S; Trimmer, KJ	1
Aspinall, S; Corkill, JE; Hart, CA; McLennan, AG	1
Cullmann, W	2
Castillo, AM; Gutierrez, J; Liebana, J; Martin, MA; Piédrola, G	1
Cavalieri, SJ; New, C; Sanders, CC	1
Jackson, D	1
Adlard, MW; Shah, AJ; Stride, JD	1
Pastorek, JG	1
Barthélémy, M; Kazmierczak, A; Labia, R; Morand, A; Péduzzi, J; Tiwari, K	1
Cordin, X; Duez, JM; Kazmierczak, A; Pechinot, A; Siebor, E; Sirot, J	1
Sutherland, R	1
Aldridge, KE; Sanders, CV	1
Barry, AL; Fuchs, PC	1
Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA	1
Földes, J; Hajdu, E; Nagy, E	1
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD	1
Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ	1
Bruckner, G; Hampel, B; Koeppe, P; Lode, H	1
Adachi, K; Ueda, S; Watanabe, M; Yamabe, S	1
Chin, NX; McElrath, MJ; Neu, HC	1
Moosdeen, F; Williams, J; Yamabe, S	1
Conner, CS	1
Grimont, PA; Hornstein, MJ; Jupeau, AM; Philippon, AM; Scavizzi, MR	1
Chapman, M; Colley, N; Houang, ET	1
Scorneaux, B; Van der Auwera, P	1
Barry, AL; Jones, RN; Packer, RR	1
Rice, RJ; Thompson, SE	1
Aldridge, KE; Marier, RL; Sanders, CV	1
McDougal, LK; Thornsberry, C	1
Aronoff, SC; Jacobs, MR; Johenning, S; Shlaes, DM; Yamabe, S	1
Guibourdenche, M; Philippon, A; Riou, JY; Sotolongo, F	1
Aronoff, SC; Jacobs, MR; Johenning, S; Yamabe, S	2
Appelbaum, PC; Jacobs, MR; Spangler, SK; Yamabe, S	1
Eggleston, M; Parker, RH	1
Ohkawa, M	1
Cynamon, MH; Sorg, TB	1
Cundy, KR; Fekete, T; McGowen, J	1
Ito, T; Tamura, M	1
Binder, S; Cullmann, W; Stieglitz, M	1
Fu, KP; Grace, ME; Gregory, FJ; Hung, PP	1
Brickley, X; Duval, J; Legrand, P; Orsoni, A; Soussy, CJ	1
Bush, K	1
Masecar, BL; Patterson, JE; Zervos, MJ	1
Barry, AL; Fuchs, PC; Jones, RN	2
Grimm, H	1
Bodey, GP; Bolivar, R; Weaver, SS	1
Brenner, DG; Knowles, JR	2
Calderwood, SB; Gardella, A; Jacoby, GA; Moellering, RC; Philippon, AM	1
Belasco, JG; Charnas, RL; Fisher, J; Khosla, S; Knowles, JR	1
Andrews, JM; Bedford, KA; Wise, R	1
Fu, KP; Neu, HC	2
Li, JT; Moosdeen, F; Williams, JD	1
Baumgärtner, M; Wundt, W	1
Fleck, WF; Heyn, B; Schröer, HP	1
Baumgärtner, M; Müller, HP; Wundt, W	1
Baumgärtner, M	1
Arakawa, Y; Horii, T; Ito, H; Ohsuka, S; Ohta, M	1
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA	1
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL	1
Chang, SC; Hsieh, WC; Luh, KT	1
Harris, EB; Hastings, RC; Prabhakaran, K; Randhawa, B	1
Manzella, JP	1
Bensoussan, F; Bensoussan, M; Bernard, E; Carsenti-Etesse, H; De Salvador, F; Dellamonica, P; Durant, J; Mondain, V; Pradier, C; Thabaut, A	1
Fastrez, J; Marchand-Brynaert, J; Vanwetswinkel, S	1
Cramp, R; Knowles, DJ; Payne, DJ; Winstanley, DJ	1
Alós, JI; Gómez-Garcés, JL; Mateos, MV	1
Frère, JM; Ghuysen, MF; Matagne, A	1
Alos, I; Baquero, F; Baquero, MR; Blazquez, J; Canton, R	1
Inoue, E; Mitsuhashi, S; Muratani, T; Nakane, T; Yokota, E	1
Mentis, AF; Tsakris, A; Tzelepi, E; Tzouvelekis, LS	1
Jin, YF; Piddock, LJ; Turner, HL	1
Barry, A; Fuchs, P; Gerlach, E; Hardy, D; McLaughlin, J; Pfaller, M	1
Gaudreau, C; Lachance, N; Lamothe, F; Turgeon, F	1
Amyes, SG; Thomson, CJ	1
Blatter, MM; Bluestone, CD; Chan, KH; Fall, PA; Reisinger, KS; Tan, LS	1
Bohman, VR; Cox, SM; Leveno, KJ; Sherman, ML	1
Farinati, AE; Fernández-Lausi, A; Jugo, MB; Villar, HE	1
Labia, R; Mariotte-Boyer, S; Nicolas-Chanoine, MH	1
Alós, JI; Balas, D; Cogollos, R; Gomez-Graces, JL; Tajada, P	1
Amicosante, G; Bonfiglio, G; Cornaglia, G; Felici, A; Oratore, A; Perilli, M; Rossolini, GM	1
Greenwood, D	1
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ	1
Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z	1
Baker, PD; Fernau, R; Landon, GC; Lipsky, BA	1
Diogo, MJ; Garite, TJ; Lovett, SM; Weiss, JD; Williams, PT	1
Hanaki, H; Nagayama, A; Nomura, S	1
Basu, D; Basu, J; Narayankumar, DV; Van Beeumen, J	1
Barthélémy, M; Chaibi, EB; Farzaneh, S; Labia, R; Péduzzi, J; Sirot, D	1
Calcagno, ML; Danelon, G; Gutkind, G; Mascaretti, O; Mata, EG; Power, P; Radice, M	1
Amicosante, G; Cornaglia, G; Franceschini, N; Mazzariol, A; Perilli, M; Segatore, B; Setacci, D	1
Anderson, V; Bonomo, RA; Knox, JR; Lin, S; Rudin, SD; Shlaes, DM; Thomas, M	1
Das, B; Goel, V; Kapil, A; Pandey, A; Seth, P; Sood, S	1
Jarlier, V	1
Kim, KH; Park, KW; Yim, CB	1
de Seny, D; Frere, JM; Galleni, M; Laraki, N; Llabres, G; Prosperi-Meys, C; Soto, RP; Valladares, MH	1
González-Lama, Z; González-Martín, M; Lupiola, P; Tejedor-Junco, MT	1
de la Pena, A; Derendorf, H	1
Baquero, F; Cantón, R; De Rafael, L; Martínez-Ferrer, M; Oliver, A; Pérez-Vázquez, M	1
Giakkoupi, P; Legakis, NJ; Tzelepi, E; Tzouvelekis, LS	1
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A	1
Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K	1
Degnan, BA; Farmer, TH; Payne, DJ	1
Bao, D; Fan, X; Liu, B; Zhou, L	1
Kotra, LP; Levesque, RC; Mobashery, S; Sanschagrin, F; Therrien, C	1
Miranda, E; Sader, HS; Sejas, L; Tosin, I	1
Levesque, RC; Palzkill, T; Sanschagrin, F; Savoie, A; Voyer, N	1
Niki, Y	1
Mealey, KL	1
Pajchel, G; Pawłowski, K; Tyski, S	1
Nakano, R; Okamoto, R	1
Bonomo, RA; Carey, MP; Carey, PR; Helfand, MS; Hujer, AM; Totir, MA	1
Higgins, PG; Seifert, H; Stefanik, D; Wisplinghoff, H	1
Høiby, N; Walther-Rasmussen, J	1
Bonomo, RA; Carey, MP; Carey, PR; Helfand, MS; Padayatti, PS; Totir, MA; van den Akker, F	1
Cooper, CE; Griffin, KE; Masters, PJ; Slocombe, B; Sutherland, R	1
Nord, CE	1
Farmer, TH; Reading, C	1
Bonomo, RA; Buynak, JD; Carey, MP; Carey, PR; Helfand, MS; Sheri, A; Totir, MA	1
Bonomo, RA; Distler, AM; Thomson, JM	1
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA	1
Buynak, JD; Carey, PR; Kalp, M; Totir, MA	1
Bethel, CR; Bonomo, RA; Drawz, SM; Ke, W; Ori, C; Prati, F; Sampson, JM; van den Akker, F	1
Bethel, CR; Bonnet, R; Bonomo, RA; Distler, AM; Endimiani, A; Hujer, AM; Hujer, KM; Papp-Wallace, K; Shyr, T; Taracila, M; Thomson, JM	1
Chitnis, DS; Chitnis, S; Hemvani, N; Katara, G	1
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V	1
Kasap, M; Torol, S	1
Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA	1
Beceiro, A; Bou, G; Galleni, M; García, P; Gómez-Bertomeu, F; González-López, JJ; Kerff, F; Larrosa, N; Méndez, JA; Miró, E; Navarro, F; Oliver, A; Pérez-Llarena, FJ; Zamorano, L	1
Lu, J; Pang, Y; Wang, Y; Zhang, D	1
Blok, A; Pannu, NS; Tassoni, R; Ubbink, M	1
Furuhashi, K; Hamada, E; Ishikawa, J; Iwaizumi, M; Maekawa, M; Nagao, Y; Nagura, O; Nanba, T; Ota, Y; Yamanaka, K	1
Chai, J; Chen, S; Cheng, Q; Wai Chi Chan, E; Xu, C; Zhang, R	1
Cardoso, MH; Costa, BO; Franco, OL	1
Fekete, T	1
Antonelli, A; Cherubini, S; D'Andrea, MM; Perilli, M; Piccirilli, A; Rossolini, GM	1
Hu, S; Lou, Z; Shen, Y; Tu, M	1

Reviews

16 review(s) available for clavulanic acid and sulbactam

Article	Year
Antibiotic therapy for pelvic inflammatory disease. The Journal of reproductive medicine, 1990, Volume: 35, Issue:3 Suppl Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Gonorrhea; Humans; Pelvic Inflammatory Disease; Sulbactam; Ticarcillin	1990
Overcoming enzymatic resistance in bacteria: impact on future therapy. The Journal of international medical research, 1990, Volume: 18 Suppl 4 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Chloramphenicol; Chloramphenicol O-Acetyltransferase; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enzyme Inhibitors; Sulbactam	1990
The pharmacokinetics of sultamicillin. APMIS. Supplementum, 1989, Volume: 5 Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Kidney Diseases; Prodrugs; Sulbactam	1989
Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985. JAMA, 1986, Apr-04, Volume: 255, Issue:13 Topics: Cephalosporins; Chlamydia Infections; Clavulanic Acid; Clavulanic Acids; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillin Resistance; Penicillins; Pharyngeal Diseases; Quinolines; Spectinomycin; Sulbactam; Syphilis; Tetracycline	1986
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance. Infection control : IC, 1987, Volume: 8, Issue:1 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Kinetics; Penicillanic Acid; Penicillin Resistance; Penicillins; Sulbactam; Ticarcillin	1987
[Clinical application of beta-lactamase inhibitors on urinary tract infections]. Nihon rinsho. Japanese journal of clinical medicine, 1986, Volume: 44, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Sulbactam; Urinary Tract Infections	1986
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors]. Nihon rinsho. Japanese journal of clinical medicine, 1987, Volume: 45, Issue:3 Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin	1987
Beta-lactamase inhibitors from laboratory to clinic. Clinical microbiology reviews, 1988, Volume: 1, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Sulbactam	1988
[Beta lactamase inhibitors, a new start of antibiotic therapy]. Deutsche medizinische Wochenschrift (1946), 1982, Aug-27, Volume: 107, Issue:34 Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Resistance, Microbial; Humans; Kinetics; Penicillanic Acid; Sulbactam	1982
Pharmacokinetic properties of beta-lactamase inhibitors. International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:2 Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam	1999
[Fundamental and clinical studies on beta-lactamase inhibitors]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:4 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	2001
Penicillins and beta-lactamase inhibitor combinations. Journal of the American Veterinary Medical Association, 2001, Jun-15, Volume: 218, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam	2001
[beta-Lactamase-inhibitor combinations]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 3 Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Design; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam	2003
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases. Canadian journal of microbiology, 2004, Volume: 50, Issue:3 Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam	2004
Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria. Current protein & peptide science, 2020, Volume: 21, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin Kinase; Nucleotidyltransferases; Sulbactam; Tazobactam	2020
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China. The American journal of tropical medicine and hygiene, 2022, 10-12, Volume: 107, Issue:4 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms	2022

Trials

5 trial(s) available for clavulanic acid and sulbactam

Article	Year
Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media. The Pediatric infectious disease journal, 1993, Volume: 12, Issue:1 Topics: Acute Disease; Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Sulbactam	1993
Randomized investigation of antimicrobials for the prevention of preterm birth. American journal of obstetrics and gynecology, 1996, Volume: 174, Issue:1 Pt 1 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Female; Gestational Age; Humans; Obstetric Labor, Premature; Penicillins; Placebos; Pregnancy; Pregnancy Outcome; Sulbactam	1996
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin	1997
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Clavulanic Acids; Diabetic Foot; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Penicillins; Prospective Studies; Sulbactam; Treatment Outcome	1997
A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. American journal of obstetrics and gynecology, 1997, Volume: 176, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Amoxicillin; Ampicillin; Antibiotic Prophylaxis; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Prospective Studies; Sulbactam	1997

Other Studies

152 other study(ies) available for clavulanic acid and sulbactam

Article	Year
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives. Journal of medicinal chemistry, 1987, Volume: 30, Issue:8 Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles	1987
N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases. Journal of medicinal chemistry, 1988, Volume: 31, Issue:2 Topics: Azetidines; Azetines; beta-Lactamase Inhibitors; Cephalosporins; Enzyme Inhibitors; Structure-Activity Relationship	1988
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(acyloxy)methyl]-2-methylpenam-3 alpha-carboxylic acid 1,1-dioxides. Journal of medicinal chemistry, 1985, Volume: 28, Issue:4 Topics: Amoxicillin; Bacteria; beta-Lactamase Inhibitors; Enzyme Inhibitors; Penicillins; Structure-Activity Relationship	1985
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus	1981
Design, synthesis and bioactivity evaluation of tribactam beta lactamase inhibitors. Bioorganic & medicinal chemistry letters, 2002, Mar-25, Volume: 12, Issue:6 Topics: Bacillus cereus; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Dose-Response Relationship, Drug; Drug Design; Hydrolysis; Models, Molecular	2002
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA	2007
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet	2007
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity	2007
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam	2007
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis	2007
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity	2008
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity	2008
Genetic variability among ampC genes from acinetobacter genomic species 3. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain	2009
In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests	2009
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2010
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA	2010
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam	2010
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin	2010
Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Inhibitory Concentration 50; Molecular Structure; Spectrometry, Mass, Electrospray Ionization	2010
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Circular Dichroism; Clavulanic Acid; Crystallography, X-Ray; Drug Design; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds	2013
Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone. Biochemistry, 2015, Jan-27, Volume: 54, Issue:3 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Biocatalysis; Catalytic Domain; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imines; Kinetics; Microbial Sensitivity Tests; Normal Distribution; Solutions; Spectrum Analysis, Raman; Sulbactam	2015
OHIO-1 beta-lactamase resistant to mechanism-based inactivators. FEMS microbiology letters, 1992, Apr-01, Volume: 71, Issue:1 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Molecular Sequence Data; Mutation; Penicillanic Acid; Plasmids; Sequence Homology, Nucleic Acid; Sulbactam; Tazobactam	1992
Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:1 Topics: Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Clostridium; Fusobacterium nucleatum; Penicillanic Acid; Sulbactam; Tazobactam	1992
Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:11 Topics: Bacteria, Anaerobic; Bacteroides; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clostridium; Fusobacterium nucleatum; Penicillanic Acid; Sulbactam; Tazobactam	1992
Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:4 Topics: Bacterial Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefpirome; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Hexosyltransferases; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus; Sulbactam	1992
Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:1 Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Sulbactam	1992
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis. Gynecologic and obstetric investigation, 1992, Volume: 33, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Female; Fetal Blood; Humans; Placenta; Pregnancy; Regression Analysis; Sulbactam; Ticarcillin	1992
Characterization of a beta-lactamase produced by Pseudomonas paucimobilis. Journal of general microbiology, 1991, Volume: 137, Issue:6 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Molecular Weight; Penicillanic Acid; Penicillin Resistance; Penicillins; Pseudomonas; Sulbactam; Tazobactam	1991
Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1991, Volume: 275, Issue:4 Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Enterobacter cloacae; Escherichia coli; Klebsiella; Penicillanic Acid; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam; Tazobactam	1991
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis. Microbios, 1991, Volume: 67, Issue:272-273 Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Humans; Microbial Sensitivity Tests; Sulbactam	1991
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:7 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Mice; Microbial Sensitivity Tests; Sulbactam; Ticarcillin	1991
Evolution of beta-lactamase inhibitors. Pharmacotherapy, 1991, Volume: 11, Issue:2 ( Pt 2) Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Sulbactam	1991
A sensitive assay for clavulanic acid and sulbactam in biological fluids by high-performance liquid chromatography and precolumn derivatization. Journal of pharmaceutical and biomedical analysis, 1990, Volume: 8, Issue:5 Topics: beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Sulbactam	1990
Interaction of beta-lactamase inhibitors with various beta-lactamases. Chemotherapy, 1990, Volume: 36, Issue:3 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Humans; Klebsiella; Penicillanic Acid; Plasmids; Proteus vulgaris; Staphylococcus aureus; Sulbactam; Tazobactam	1990
Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria. The Journal of international medical research, 1990, Volume: 18 Suppl 4 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enzyme Induction; Microbial Sensitivity Tests; Sulbactam	1990
Development of beta-lactamase inhibitors. The Journal of reproductive medicine, 1990, Volume: 35, Issue:3 Suppl Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Drugs, Investigational; Humans; Penicillins; Sulbactam; Ticarcillin	1990
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey. The Journal of reproductive medicine, 1990, Volume: 35, Issue:3 Suppl Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin	1990
Implications of beta-lactamase-inhibitor combinations. The Journal of reproductive medicine, 1990, Volume: 35, Issue:3 Suppl Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam; Ticarcillin	1990
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin	1990
Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae. The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:4 Topics: Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Sulbactam	1990
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin	1989
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:11 Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	1989
The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:5 Topics: beta-Lactamase Inhibitors; Cell Division; Cells, Cultured; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam; Tazobactam	1987
Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chemotherapy, 1988, Volume: 34, Issue:4 Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Penicillanic Acid; Sulbactam	1988
The activity of a sulphone beta-lactamase inhibitor, YTR 830. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid; R Factors; Sulbactam; Tazobactam	1987
beta-Lactamase inhibitors. Drug intelligence & clinical pharmacy, 1985, Volume: 19, Issue:6 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Sulbactam	1985
In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Yersinia enterocolitica	1985
Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:1 Topics: Adult; Amoxicillin; Ampicillin; Ascitic Fluid; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Female; Humans; Injections, Intravenous; Kinetics; Middle Aged; Pelvis; Penicillanic Acid; Peritoneum; Sulbactam	1985
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Campylobacter fetus; Clavulanic Acid; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1985
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:1 Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin	1986
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1986
The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. Journal of clinical microbiology, 1986, Volume: 23, Issue:5 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus aureus; Sulbactam	1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:6 Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Gram-Negative Aerobic Bacteria; Penicillanic Acid; Penicillins; Plasmids; Sulbactam; Tazobactam	1986
Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases. Drugs, 1986, Volume: 31 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Isoelectric Focusing; Microbial Sensitivity Tests; Neisseriaceae; Penicillanic Acid; Sulbactam	1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2 Topics: Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Mezlocillin; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas; Sulbactam; Ticarcillin	1986
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1986
Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1 Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Penicillanic Acid; Sulbactam	1987
Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2 Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; Cefazolin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1987
[Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin]. Immunitat und Infektion, 1987, Volume: 15, Issue:3 Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Humans; Kinetics; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1987
Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases. Drugs under experimental and clinical research, 1987, Volume: 13, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cephamycins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1987
[Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cephalosporins; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; Thienamycins	1988
Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1 Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Penicillinase; Penicillins; Phenotype; R Factors; Sulbactam	1988
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid. Journal of clinical microbiology, 1988, Volume: 26, Issue:6 Topics: Amoxicillin; Ampicillin; Bacteria, Anaerobic; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Sulbactam	1988
[In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria]. Arzneimittel-Forschung, 1987, Volume: 37, Issue:10 Topics: Ampicillin; Ampicillin Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Sulbactam	1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria. Diagnostic microbiology and infectious disease, 1987, Volume: 8, Issue:1 Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam	1987
Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms. Diagnostic microbiology and infectious disease, 1984, Volume: 2, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacter; Gram-Negative Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas; Sulbactam	1984
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:4 Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Sulbactam; Tazobactam	1984
Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli. Biochemistry, 1984, Nov-20, Volume: 23, Issue:24 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Stability; Escherichia coli; Isoelectric Focusing; Penicillanic Acid; Spectrophotometry; Sulbactam; Tritium	1984
6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli. Biochemistry, 1984, Nov-20, Volume: 23, Issue:24 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding, Competitive; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Hydrolysis; Isomerism; Kinetics; Penicillanic Acid; Penicillin G; Spectrophotometry, Ultraviolet; Sulbactam	1984
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:2 Topics: Azlocillin; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Imipenem; Penicillanic Acid; Penicillin Resistance; Pseudomonas aeruginosa; Species Specificity; Sulbactam; Thienamycins	1982
Beta-lactamase inactivation by mechanism-based reagents. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 1980, May-16, Volume: 289, Issue:1036 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Lactams; Penicillanic Acid; Sulbactam	1980
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins. The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:2 Topics: Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam	1980
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors. Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Penicillins; Piperacillin; Sulbactam	1980
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors. The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam	1981
The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells. The Journal of antimicrobial chemotherapy, 1982, Volume: 9, Issue:4 Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephaloridine; Clavulanic Acid; Hydrolysis; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam	1982
[Biological effects of coordination compounds of transitional metals. The beta-lactamase inhibitory effect of cis-platin, 2-aminopyridine palladium chloride, clavulanic acid and penicillanic acid sulfonate CP 45,899 in the nitrocefin test and Titertek/mic Zeitschrift fur allgemeine Mikrobiologie, 1983, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Bacillus cereus; beta-Lactamase Inhibitors; Cisplatin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Organometallic Compounds; Palladium; Penicillanic Acid; Picolines; Sulbactam	1983
[Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria]. Arzneimittel-Forschung, 1983, Volume: 33, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefsulodin; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Netilmicin; Penicillanic Acid; Sulbactam	1983
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs]. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1983, Volume: 254, Issue:2 Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam	1983
Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Hydrogen-Ion Concentration; Kinetics; Penicillanic Acid; Sulbactam; Tazobactam	1995
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20 Suppl 2 Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin	1995
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species. Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam	1995
Influence of beta-lactamase inhibitors on the activity of oxacillin against methicillin-resistant Staphylococcus aureus. Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Staphylococcus aureus; Sulbactam; Tazobactam	1995
beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic. Microbios, 1995, Volume: 81, Issue:328 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cell Division; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Penicillanic Acid; Streptomycin; Sulbactam; Tazobactam	1995
Parenteral beta-lactamase inhibitor combinations for clinical use. American family physician, 1995, May-15, Volume: 51, Issue:7 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Sulbactam; Ticarcillin	1995
Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:12 Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Multiple; Drug Synergism; Microbial Sensitivity Tests; Selection, Genetic; Streptococcus pneumoniae; Sulbactam	1994
Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases. The Journal of antibiotics, 1994, Volume: 47, Issue:9 Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Penicillanic Acid; Sulbactam; Sulfonamides; Sulfones	1994
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:4 Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Penicillanic Acid; Plasmids; Sulbactam; Tazobactam	1994
[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam]. Medicina clinica, 1994, Feb-12, Volume: 102, Issue:5 Topics: Aged; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Penicillanic Acid; Sulbactam; Tazobactam	1994
Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview. The Biochemical journal, 1993, Nov-01, Volume: 295 ( Pt 3) Topics: Actinomycetales; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Kinetics; Lactams; Serine; Streptomyces; Sulbactam	1993
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:10 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Cloning, Molecular; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Humans; Mutation; Penicillanic Acid; Phenotype; Sulbactam; Tazobactam	1993
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1993
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillinase; Plasmids; Sulbactam	1993
Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Lactams; Penicillanic Acid; Sulbactam; Tazobactam	1993
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:3 Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1993
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Clavulanic Acid; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1993
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:5 Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; Isoelectric Focusing; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Plasmids; Restriction Mapping; Sulbactam; Tazobactam	1993
[Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid]. Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:5 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Microbial Sensitivity Tests; Predictive Value of Tests; Reproducibility of Results; Sulbactam	1996
A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins. FEMS microbiology letters, 1996, Sep-15, Volume: 143, Issue:1 Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Cephamycins; Clavulanic Acid; Clavulanic Acids; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Kinetics; Molecular Structure; Penicillanic Acid; Recombinant Proteins; Substrate Specificity; Sulbactam; Tazobactam	1996
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Campylobacter coli; Campylobacter jejuni; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam	1996
Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3 Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Sulbactam	1996
Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests? The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:1 Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1996
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin	1996
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:2 Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections	1997
Characterization of a beta-lactamase from Mycobacterium smegmatis SN2. Biochemistry and molecular biology international, 1997, Volume: 43, Issue:3 Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Enzyme Inhibitors; Molecular Sequence Data; Mycobacterium; Penicillanic Acid; Sequence Alignment; Substrate Specificity; Sulbactam	1997
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling. Biochimica et biophysica acta, 1998, Jan-15, Volume: 1382, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Kinetics; Models, Molecular; Molecular Conformation; Penicillanic Acid; Protein Conformation; Sulbactam; Tazobactam	1998
Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:2 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Enzyme Inhibitors; Penicillanic Acid; Sulbactam; Tazobactam	1998
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Interactions; Drug Resistance, Multiple; Enzyme Inhibitors; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Penicillanic Acid; Providencia; Sulbactam; Tazobactam	1998
Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme. The Biochemical journal, 1998, Jul-15, Volume: 333 ( Pt 2) Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Circular Dichroism; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Isoleucine; Kinetics; Methionine; Microbial Sensitivity Tests; Penicillanic Acid; Point Mutation; Protein Conformation; Sulbactam; Tazobactam	1998
In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii. Journal of clinical microbiology, 1998, Volume: 36, Issue:11 Topics: Acinetobacter; Acinetobacter Infections; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Clavulanic Acid; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Sulbactam	1998
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor]. Presse medicale (Paris, France : 1983), 1998, Volume: 27 Suppl 4 Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Haemophilus influenzae; Humans; Klebsiella; Klebsiella pneumoniae; Moraxella catarrhalis; Penicillanic Acid; Proteus vulgaris; Staphylococcus aureus; Streptococcus pneumoniae; Sulbactam; Tazobactam	1998
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model. Archives of pharmacal research, 1998, Volume: 21, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles	1998
Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases. FEBS letters, 1999, Jan-25, Volume: 443, Issue:2 Topics: beta-Lactamases; Binding Sites; Catalysis; Clavulanic Acid; Isomerism; Penicillanic Acid; Substrate Specificity; Sulbactam; Tazobactam	1999
Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics. Folia microbiologica, 1998, Volume: 43, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefoxitin; Cephamycins; Clavulanic Acid; Cloxacillin; Enterobacter cloacae; Enzyme Inhibitors; Genes, Bacterial; Microbial Sensitivity Tests; p-Chloromercuribenzoic Acid; Penicillin Resistance; Penicillins; Plasmids; Sulbactam; Sulfhydryl Reagents	1998
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4 Topics: Amoxicillin; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli; Humans; Microbial Sensitivity Tests; Phenotype; Sulbactam	1999
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	1999
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin	1999
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis]. Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:5 Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant	1999
Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria. FEMS microbiology letters, 1999, Jul-01, Volume: 176, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cell Membrane Permeability; Clavulanic Acid; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Lactams; Penicillanic Acid; Periplasm; Sulbactam; Tazobactam	1999
[Study on the beta-lactamases of the Escherichia coli HX88108 resistant to ceforperazon]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1998, Volume: 29, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Sulbactam	1998
Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors. FEBS letters, 2000, Mar-31, Volume: 470, Issue:3 Topics: Acylation; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbenicillin; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Escherichia coli; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Penicillanic Acid; Penicillin Resistance; Penicillinase; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thermodynamics	2000
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2000, Volume: 4, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin	2000
Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases. Protein engineering, 2000, Volume: 13, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Circular Dichroism; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Recombinant Proteins; Structure-Activity Relationship; Sulbactam; Tazobactam	2000
CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections. Journal of pharmaceutical and biomedical analysis, 2002, Jun-20, Volume: 29, Issue:1-2 Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clavulanic Acid; Drug Therapy, Combination; Electrophoresis, Capillary; Sulbactam	2002
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography. Biochemistry, 2003, Nov-25, Volume: 42, Issue:46 Topics: Amines; Amino Acid Substitution; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Crystallization; Deuterium Oxide; Enzyme Inhibitors; Kinetics; Microscopy; Models, Molecular; Penicillanic Acid; Recombinant Proteins; Spectrum Analysis, Raman; Sulbactam; Tazobactam; Water	2003
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	2004
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase. The Journal of biological chemistry, 2005, Oct-14, Volume: 280, Issue:41 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Binding Sites; Clavulanic Acid; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Klebsiella pneumoniae; Models, Chemical; Models, Molecular; Mutation; Penicillanic Acid; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Serine; Spectrum Analysis, Raman; Sulbactam; Tazobactam; Time Factors; X-Rays	2005
Comparative activities in vitro of amoxycillin/clavulanic acid and ampicillin/sulbactam. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Amoxicillin; Animals; Bacteria; Clavulanic Acid; Drug Therapy, Combination; Haemophilus influenzae; Horses; Microbial Sensitivity Tests; Penicillin Resistance; Sulbactam	1989
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	1989
The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: beta-Lactamases; Clavulanic Acid; Enzyme Induction; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam	1989
Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase. Biochemistry, 2007, Aug-07, Volume: 46, Issue:31 Topics: Acrylates; Amino Acid Substitution; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Crystallization; Enzyme Inhibitors; Imines; Kinetics; Molecular Structure; Penicillanic Acid; Recombinant Proteins; Serine; Spectrum Analysis, Raman; Sulbactam; Tazobactam	2007
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Biochemistry, 2007, Oct-09, Volume: 46, Issue:40 Topics: Amino Acid Substitution; Ampicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Kinetics; Mass Spectrometry; Molecular Structure; Plasmids; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Sulbactam	2007
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes. American journal of obstetrics and gynecology, 2008, Volume: 198, Issue:5 Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam	2008
Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence. Journal of the American Chemical Society, 2009, Feb-18, Volume: 131, Issue:6 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Crystallography, X-Ray; Enzyme Inhibitors; Imines; Penicillanic Acid; Quantum Theory; Spectrum Analysis, Raman; Sulbactam; Tazobactam	2009
Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: beta-Lactamase Inhibitors; Boronic Acids; Cefoperazone; Ceftazidime; Clavulanic Acid; Enzyme Inhibitors; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Penicillanic Acid; Sulbactam; Tazobactam	2011
Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli Proteins; Kinetics; Meropenem; Molecular Dynamics Simulation; Molecular Structure; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam; Tazobactam; Thienamycins	2011
Augmentation in zone of inhibition of cefoperazone/cefoperazone+ sulbactum compares well with the clinical laboratory standard institute standard extended spectrum beta-lactamase detection method as well as the polymerase chain reaction method. Current drug safety, 2011, Volume: 6, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam	2011
Class A carbapenemase FPH-1 from Francisella philomiragia. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins	2012
Purification and characterization of OXA-23 from Acinetobacter baumannii. Journal of enzyme inhibition and medicinal chemistry, 2013, Volume: 28, Issue:4 Topics: Acinetobacter baumannii; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Dose-Response Relationship, Drug; Enzyme Activation; Escherichia coli; Kinetics; Models, Molecular; Penicillanic Acid; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Surface Properties; Tazobactam	2013
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins	2012
Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Clavulanic Acid; Enterobacter cloacae; Escherichia coli; Humans; Klebsiella oxytoca; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	2014
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam; Thienamycins; Tuberculosis, Multidrug-Resistant	2016
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis. Biochemistry, 2019, 02-19, Volume: 58, Issue:7 Topics: Acylation; Aldehydes; Amino Acid Substitution; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Crystallography, X-Ray; Mycobacterium tuberculosis; Protein Conformation; Serine; Sulbactam; Tazobactam	2019
Detection of extended-spectrum β-lactamases producing Enterobacteriaceae using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry based MBT STAR-BL software module with β-lactamase inhibition assay depends on the bacterial stra Journal of microbiological methods, 2019, Volume: 167 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Clavulanic Acid; Enterobacteriaceae; Humans; Hydrolysis; Microbial Sensitivity Tests; Software; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam	2019
Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S ACS infectious diseases, 2020, 04-10, Volume: 6, Issue:4 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Catalytic Domain; Clavulanic Acid; Crystallography; Drug Resistance, Multiple, Bacterial; Hydrolysis; Mass Spectrometry; Models, Molecular; Sulbactam	2020
Fluoroquinolones vs. amoxicillin-clavulanate or ampicillin-sulbactam were not linked to aortic aneurysm or dissection. Annals of internal medicine, 2021, Volume: 174, Issue:2 Topics: Amoxicillin; Ampicillin; Aortic Aneurysm; Aortic Dissection; Clavulanic Acid; Dissection; Fluoroquinolones; Humans; Sulbactam	2021
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Clavulanic Acid; Kinetics; Plasmids; Sulbactam; Tazobactam	2022